Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis

Mona Bafadhel, Lisa Davies, Peter M.A. Calverley, Shawn D. Aaron, Christopher E. Brightling, Ian D. Pavord
European Respiratory Journal 2014 44: 789-791; DOI: 10.1183/09031936.00062614
Mona Bafadhel
1Dept of Respiratory Medicine, Nuffield Dept of Medicine, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mona.bafadhel@ndm.ox.ac.uk
Lisa Davies
2Aintree Chest Centre, University Hospital Aintree, Liverpool, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter M.A. Calverley
2Aintree Chest Centre, University Hospital Aintree, Liverpool, UK
3Institute of Ageing and Chronic Diseases, University of Liverpool, Liverpool, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shawn D. Aaron
4Dept of Medicine, The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher E. Brightling
5Institute for Lung Health, NIHR Respiratory Biomedical Research Unit, University of Leicester, Leicester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian D. Pavord
1Dept of Respiratory Medicine, Nuffield Dept of Medicine, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 44 no. 3 789-791
DOI 
https://doi.org/10.1183/09031936.00062614
PubMed 
24925917

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Received April 2, 2014
  • Accepted April 21, 2014
  • Published online August 31, 2014.

Article Versions

  • previous version (June 12, 2014 - 07:02).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©ERS 2014

Author Information

  1. Mona Bafadhel1⇑,
  2. Lisa Davies2,
  3. Peter M.A. Calverley2,3,
  4. Shawn D. Aaron4,
  5. Christopher E. Brightling5 and
  6. Ian D. Pavord1
  1. 1Dept of Respiratory Medicine, Nuffield Dept of Medicine, University of Oxford, Oxford, UK
  2. 2Aintree Chest Centre, University Hospital Aintree, Liverpool, UK
  3. 3Institute of Ageing and Chronic Diseases, University of Liverpool, Liverpool, UK
  4. 4Dept of Medicine, The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada
  5. 5Institute for Lung Health, NIHR Respiratory Biomedical Research Unit, University of Leicester, Leicester, UK
  1. Mona Bafadhel, Dept of Respiratory Medicine, Nuffield Dept of Medicine, NDM Research Building, University of Oxford, Old Road Campus, Oxford, OX3 7FZ, UK. E-mail: mona.bafadhel{at}ndm.ox.ac.uk
View Full Text

Article usage

Article usage: June 2014 to April 2023

AbstractFullPdf
Jun 2014358072
Jul 2014184036
Aug 2014153942
Sep 201434081164
Oct 2014995660
Nov 20141222848
Dec 2014463230
Jan 2015653731
Feb 2015451925
Mar 2015572232
Apr 2015752031
May 2015493129
Jun 2015493844
Jul 2015322331
Aug 2015522418
Sep 20151002821
Oct 20152319965
Nov 20151365154
Dec 20151133320
Jan 20161104233
Feb 20161242949
Mar 2016187254
Apr 2016217860
May 20169010973
Jun 2016289570
Jul 2016207755
Aug 2016237360
Sep 2016227155
Oct 2016229954
Nov 2016338756
Dec 2016246731
Jan 2017176841
Feb 2017229460
Mar 2017267850
Apr 2017315538
May 2017168977
Jun 2017195532
Jul 2017265835
Aug 2017327561
Sep 20174510577
Oct 2017398973
Nov 2017228063
Dec 2017275942
Jan 2018247043
Feb 2018329053
Mar 2018228465
Apr 2018308274
May 2018267653
Jun 2018218947
Jul 2018256043
Aug 2018247645
Sep 201885643
Oct 2018137653
Nov 201896043
Dec 201887043
Jan 201956548
Feb 201944833
Mar 201994850
Apr 201995651
May 2019277350
Jun 201964035
Jul 2019178549
Aug 2019135842
Sep 201976752
Oct 2019104940
Nov 201944736
Dec 201952931
Jan 202063923
Feb 202086049
Mar 202084821
Apr 2020263840
May 202094233
Jun 202052425
Jul 202004124
Aug 202063621
Sep 202084525
Oct 2020146337
Nov 202055829
Dec 2020125724
Jan 202144224
Feb 202173421
Mar 202123918
Apr 2021128024
May 2021179823
Jun 2021125116
Jul 2021145039
Aug 202197426
Sep 2021106021
Oct 2021106342
Nov 2021149546
Dec 20211612420
Jan 202299336
Feb 2022167921
Mar 2022127617
Apr 202257417
May 2022137928
Jun 202212911
Jul 2022126418
Aug 202255821
Sep 202257025
Oct 202287113
Nov 202286815
Dec 202234915
Jan 2023105718
Feb 202374111
Mar 202336414
Apr 202354421

Altmetrics

PreviousNext
Back to top
View this article with LENS
Vol 44 Issue 3 Table of Contents
European Respiratory Journal: 44 (3)
  • Table of Contents
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis
Mona Bafadhel, Lisa Davies, Peter M.A. Calverley, Shawn D. Aaron, Christopher E. Brightling, Ian D. Pavord
European Respiratory Journal Sep 2014, 44 (3) 789-791; DOI: 10.1183/09031936.00062614

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis
Mona Bafadhel, Lisa Davies, Peter M.A. Calverley, Shawn D. Aaron, Christopher E. Brightling, Ian D. Pavord
European Respiratory Journal Sep 2014, 44 (3) 789-791; DOI: 10.1183/09031936.00062614
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • COPD and smoking
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Airway immune responses to COVID-19 vaccination in COPD patients
  • Wider access to rifapentine-based regimens is needed for TB care globally
  • Association between immunosuppressants and outcomes of COVID-19
Show more Agora

Research letters

  • Airway immune responses to COVID-19 vaccination in COPD patients
  • Wider access to rifapentine-based regimens is needed for TB care globally
  • Association between immunosuppressants and outcomes of COVID-19
Show more Research letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society